-
Mashup Score: 3Another Option for Metastatic Prostate Cancer | Cancer Today - 24 day(s) ago
PSMA-targeted therapy, which delivers radiation directly to cancer cells, provides a new approach for those whose prostate cancer stops responding to other treatments.
Source: www.cancertodaymag.orgCategories: General Medicine NewsTweet
-
Mashup Score: 3Alicia K. Morgans, MD, MPH, FASCO, on How Does Androgen Receptor Inhibition Affect Quality of Life? - 2 month(s) ago
Alicia K. Morgans, MD, MPH, FASCO, of Dana-Farber Cancer Institute, discusses health-related quality-of-life data from the phase III ARAN OTE trial, which evaluated the androgen receptor inhibitor darolutamide in combination with androgen-deprivation therapy (ADT) vs ADT plus placebo for patients with metastatic hormone-sensitive prostate cancer (Abstract 5004). Disclaimer: This video transcript has not been proofread or edited and may contain errors. On behalf of the ARASENS investigators, I was very
Source: ascopost.comCategories: General Medicine NewsTweet-
From #ASCO25: Dr. Alicia Morgans @CaPsurvivorship discusses health-related quality-of-life data from the phase III ARANOTE trial https://t.co/ImUXViqgf4
-
-
Mashup Score: 5
Basic science discoveries made by Dana-Farber’s William G. Kaelin Jr., MD, and his colleagues are propelling powerful new therapies for kidney cancer.
Source: www.dana-farber.orgCategories: General Medicine NewsTweet-
Chain Reaction: The Belzutifan Journey How Researchers Harnessed the Momentum of Discovery to Create a New Kidney Cancer Drug @DrChoueiri @kaelin_lab https://t.co/VK6CQwJJlu
-
-
Mashup Score: 8Mass. oncologist on prostate cancer after Biden announces diagnosis - 2 month(s) ago
Dr. Alicia Morgans, a genitourinary oncologist at the Dana-Farber Cancer Institute, says prostate cancer is treatable and the diagnosis isn’t necessarily a death sentence.
Source: www.yahoo.comCategories: General Medicine NewsTweet-
Lank Center's Dr. Alicia Morgans comments on former President Biden's prostate cancer diagnosis https://t.co/DWIW5hpqUX
-
-
Mashup Score: 8Mass. oncologist on prostate cancer after Biden announces diagnosis - 2 month(s) ago
Dr. Alicia Morgans, a genitourinary oncologist at the Dana-Farber Cancer Institute, says prostate cancer is treatable and the diagnosis isn’t necessarily a death sentence.
Source: www.yahoo.comCategories: General Medicine NewsTweet-
Lank Center's Dr. Alicia Morgans comments on former President Biden's prostate cancer diagnosis https://t.co/DWIW5hpqUX
-
-
Mashup Score: 5
Basic science discoveries made by Dana-Farber’s William G. Kaelin Jr., MD, and his colleagues are propelling powerful new therapies for kidney cancer.
Source: www.dana-farber.orgCategories: General Medicine NewsTweet-
Chain Reaction: The Belzutifan Journey How Researchers Harnessed the Momentum of Discovery to Create a New Kidney Cancer Drug @DrChoueiri @kaelin_lab https://t.co/VK6CQwJJlu
-
-
Mashup Score: 6Cancer Centers Survivorship Research Forum 2025 - 3 month(s) ago
Join us for a 2-day event to hear about the latest findings & gaps in Cancer Survivorship research & connect with colleagues & collaborators
Source: www.eventbrite.comCategories: General Medicine NewsTweet-
Want to hear about the latest findings & gaps in Cancer Survivorship research? 3rd Biennial Cancer Centers Survivorship Research Forum (CCSRF) at Dana-Farber Cancer Institute September 18th & 19th, 2025 Draft agenda and link to register below 👇 https://t.co/lQqLzyqvjb
-
-
Mashup Score: 8
The goals of this CME program are to increase awareness among clinicians about the need for comprehensive cancer survivorship care and specific areas where improved survivorship care can lead to improved patient outcomes. This program will educate participants regarding the evolving evidence surrounding the unique medical risks and psychosocial concerns that cancer survivors face from diagnosis through long-term survivorship. The participants will learn to recognize evidence-based screening, prevention and management strategies for potential long-term, late effects and how to tailor these for patients at varying risks for problems. This course will also introduce, highlight and encourage the participant to utilize the emerging body of guidelines, tools, and resources that are available to optimize the coordination and delivery of survivorship care. We have added several modules to this second version of our course to address specific groups and types of survivors that were not covered
Source: cmecatalog.hms.harvard.eduCategories: General Medicine NewsTweet-
Calling all healthcare professionals! Enhance your knowledge of cancer survivorship with this on-demand CME course co-directed by @CaPsurvivorship. Discover evidence-based strategies to support your patients' long-term health. #CME #CancerSurvivorship https://t.co/1D3Bo346Yb
-
-
Mashup Score: 3
The goals of this CME program are to increase awareness among clinicians about the need for comprehensive cancer survivorship care and specific areas where improved survivorship care can lead to improved patient outcomes. This program will educate participants regarding the evolving evidence surrounding the unique medical risks and psychosocial concerns that cancer survivors face from diagnosis through long-term survivorship. The participants will learn to recognize evidence-based screening, prevention and management strategies for potential long-term, late effects and how to tailor these for patients at varying risks for problems. This course will also introduce, highlight and encourage the participant to utilize the emerging body of guidelines, tools, and resources that are available to optimize the coordination and delivery of survivorship care. We have added several modules to this second version of our course to address specific groups and types of survivors that were not covered
Source: cmecatalog.hms.harvard.eduCategories: General Medicine News, Oncologists1Tweet-
Calling all healthcare professionals! Enhance your knowledge of cancer survivorship with this on-demand CME course co-directed by @CaPsurvivorship. Discover evidence-based strategies to support your patients' long-term health. #CME #CancerSurvivorship https://t.co/1D3Bo346Yb
-
-
Mashup Score: 5ESMO 2024 Kidney Cancer Highlights - 9 month(s) ago
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates you need to …
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
Drs. Wenxin (Vincent) Xu (@VincentWenxinXu) and Toni Choueiri (@DrChoueiri) covered kidney cancer updates from #ESMO24 https://t.co/tU90AtvOaq
-
Dr. Praful Ravi @PrafulRavi1 spoke about PSMA-targeted therapy for patients with prostate cancer in the Summer 2025 issue of @CancerTodayMag https://t.co/sxXAKHPskm